Laviana announced the completion of 100 million yuan B round financing, to build small molecule innovative medicine production technology research and development, process optimization, pilot and large-scale production and other one-stop service platform. This round of financing by Huayi lead investor capital, Ji Feng capital, abc capital and jingyun pharmaceutical with investment. The favor of many investors is highly affirmative to Laviana.

The lead cast Huayi capital, focus on the medical and health industry, covering the area of investment in high-tech medical field. Huayi investment in different stages of project funds, mainly concentrated in the early growth stage, the global health program in the United States, Canada, Israel, Germany, France have set up branches or strategic partners. At present, a number of domestic securities and listed companies have been set up to launch a number of medical industry funds. He won many awards such as "the top 100 of China's venture capital organization in 2017".